Edition:
United States

Proteostasis Therapeutics Inc (PTI.OQ)

PTI.OQ on NASDAQ Stock Exchange Global Market

4.93USD
10:23am EST
Change (% chg)

$-0.06 (-1.20%)
Prev Close
$4.99
Open
$5.05
Day's High
$5.11
Day's Low
$4.85
Volume
113,701
Avg. Vol
170,172
52-wk High
$16.65
52-wk Low
$1.41

Select another date:

Wed, Dec 13 2017

BRIEF-Proteostasis Therapeutics Prices Public Offering Of 8 Mln Shares At $5/Share

* PROTEOSTASIS THERAPEUTICS PRICES PUBLIC OFFERING OF COMMON STOCK

BRIEF-Proteostasis Therapeutics Announces Positive Clinical Results From Cystic FibrosisStudies

* PROTEOSTASIS THERAPEUTICS ANNOUNCES POSITIVE CLINICAL RESULTS FROM STUDIES OF PTI-428, PTI-801 AND PTI-808 IN HEALTHY VOLUNTEERS AND PATIENTS WITH CYSTIC FIBROSIS

BRIEF-Proteostasis Therapeutics Q3 loss per share $0.56

* Proteostasis Therapeutics reports third quarter 2017 results and provides CF portfolio update

BRIEF-Proteostasis Therapeutics to prioritize resources on cystic fibrosis R&D

* Proteostasis Therapeutics - ‍initiated strategic prioritization to focus resources on research & development of cystic fibrosis programs, among others​

BRIEF-Proteostasis Therapeutics appoints Helen Boudreau as CFO

* Proteostasis appoints Helen Boudreau as chief financial officer

Select another date: